written on 21.05.2014

Expanded accelerated approvals, trial networks could propel drugs to patients


If Congress wants to ensure the pace of discovery, development and delivery of innovative new therapies is accelerated – with the ultimate goal of treatments reaching patients more quickly – the existing statutory and regulatory authorities…

Latest Reports